Conflictos de Interés
•
I was employee from ICR and RMH during the development
of Abiraterone which have a financial interest in this
compound
•
I have received research funding from Janssen, Bayer,
Medivation, GSK and AZ
•
I have served as advisor and speaker for AZ, Cougar,
Janssen, Aragon, TOKAI, Medivation, Astellas (including
OSI), Bayer and Genetech
•
I have received travel support from Astellas, AZ, GSK, OSI
(now Astellas), Janssen, Bayer and Pfizer
